SYSTEMATIC REVIEW
Published on 27 Nov 2024
Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics
doi 10.3389/fphar.2024.1356634
- 275 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Future of Hematologic Malignancy Treatment: Novel Target Discovery and Epigenetic Drug Development
The Future of Hematologic Malignancy Treatment: Novel Target Discovery and Epigenetic Drug Development
4,200
Total Downloads
12k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 12 Nov 2024
Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects
doi 10.3389/fonc.2024.1445794
- 373 views
ORIGINAL RESEARCH
Published on 31 Jul 2024
MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
doi 10.3389/fphar.2024.1441383
- 666 views
REVIEW
Published on 04 Jun 2024
Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets
doi 10.3389/fphar.2024.1388903
- 1,388 views
- 1 citation
REVIEW
Published on 16 Apr 2024
The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment
doi 10.3389/fphar.2024.1376955
- 754 views
ORIGINAL RESEARCH
Published on 08 Jan 2024
Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells
doi 10.3389/fphar.2023.1331687
- 1,035 views
MINI REVIEW
Published on 07 Dec 2023
Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications
doi 10.3389/fphar.2023.1322937
- 3,757 views
- 3 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 12kTopic views
- 7,470Article views
- 4,200Article downloads